Smith & Nephew plc (SNN)

USD 24.97

(-2.65%)

Total Assets Summary of Smith & Nephew plc

  • Smith & Nephew plc's latest annual total assets in 2023 was 9.98 Billion USD , up 0.21% from previous year.
  • Smith & Nephew plc's latest quarterly total assets in 2024 Q2 was 10.54 Billion USD , down 0.0% from previous quarter.
  • Smith & Nephew plc reported annual total assets of 9.96 Billion USD in 2022, down -8.74% from previous year.
  • Smith & Nephew plc reported annual total assets of 10.92 Billion USD in 2021, down -0.84% from previous year.
  • Smith & Nephew plc reported quarterly total assets of 9.84 Billion USD for 2023 Q2, down 0.0% from previous quarter.
  • Smith & Nephew plc reported quarterly total assets of 9.98 Billion USD for 2023 FY, up 0.21% from previous quarter.

Annual Total Assets Chart of Smith & Nephew plc (2023 - 1989)

Historical Annual Total Assets of Smith & Nephew plc (2023 - 1989)

Year Total Assets Total Assets Growth
2023 9.98 Billion USD 0.21%
2022 9.96 Billion USD -8.74%
2021 10.92 Billion USD -0.84%
2020 11.01 Billion USD 18.42%
2019 9.29 Billion USD 15.39%
2018 8.05 Billion USD 2.45%
2017 7.86 Billion USD 7.11%
2016 7.34 Billion USD 2.47%
2015 7.16 Billion USD -1.9%
2014 7.3 Billion USD 25.55%
2013 5.81 Billion USD 3.14%
2012 5.64 Billion USD 18.85%
2011 4.74 Billion USD 0.3%
2010 4.73 Billion USD 3.68%
2009 4.56 Billion USD 1.26%
2008 4.5 Billion USD 1.05%
2007 4.46 Billion USD 38.07%
2006 3.23 Billion USD 8.57%
2005 2.97 Billion USD 1.94%
2004 2.91 Billion USD 31.35%
2003 2.22 Billion USD 11.52%
2002 1.99 Billion USD 24.66%
2001 1.59 Billion USD 11.22%
2000 1.43 Billion USD -9.36%
1999 1.58 Billion USD 5.53%
1998 1.5 Billion USD 5.29%
1997 1.42 Billion USD -1.0%
1996 1.44 Billion USD 13.29%
1995 1.27 Billion USD -3.74%
1994 1.32 Billion USD 1.15%
1993 1.3 Billion USD -2.8%
1992 1.34 Billion USD -15.04%
1991 1.58 Billion USD 3.19%
1990 1.53 Billion USD 13.35%
1989 1.35 Billion USD 6.28%

Peer Total Assets Comparison of Smith & Nephew plc

Name Total Assets Total Assets Difference
Abbott Laboratories 73.21 Billion USD 86.359%
Allurion Technologies Inc. 71.71 Million USD -13826.539%
Artivion, Inc. 792.39 Million USD -1160.353%
Avanos Medical, Inc. 1.69 Billion USD -490.109%
Butterfly Network, Inc. 304.27 Million USD -3182.239%
Butterfly Network, Inc. 304.27 Million USD -3182.239%
Bio-Rad Laboratories, Inc. 12.29 Billion USD 18.799%
Boston Scientific Corporation 35.13 Billion USD 71.576%
CONMED Corporation 2.3 Billion USD -334.213%
Edwards Lifesciences Corporation 9.36 Billion USD -6.662%
Paragon 28, Inc. 340.69 Million USD -2831.326%
Glaukos Corporation 940.41 Million USD -961.979%
Globus Medical, Inc. 5.08 Billion USD -96.359%
Inspire Medical Systems, Inc. 676.81 Million USD -1375.597%
Integer Holdings Corporation 2.94 Billion USD -239.388%
Medtronic plc 89.98 Billion USD 88.901%
Myomo, Inc. 14.58 Million USD -68390.577%
Nevro Corp. 635.71 Million USD -1470.992%
Owlet, Inc. 44.12 Million USD -22534.454%
Penumbra, Inc. 1.55 Billion USD -541.712%
Vicarious Surgical Inc. 119.86 Million USD -8231.943%
Sonendo, Inc. 78.16 Million USD -12677.636%
STERIS plc 11.06 Billion USD 9.732%
Stryker Corporation 39.91 Billion USD 74.977%
Vapotherm, Inc. 77.61 Million USD -12767.027%
Zimmer Biomet Holdings, Inc. 21.49 Billion USD 53.542%